Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment
This clinical trial evaluates the tolerability of a physical activity program in head and neck cancer patients who are undergoing cancer treatment. The goal of this trial is to give patients exercises prescribed by a physical therapist that they are able to complete regularly at home. Increasing physical activity may help patients reduce fatigue, improve mood, increase physical performance, and decrease joint pain.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
Plus 4 other study approaches.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated May 22, 2025 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Thomas Jefferson University
- Interventions being studied
- Other: Medical Device Usage and Evaluation; Other: Consultation; Other: Exercise Intervention; Behavioral: Behavioral Intervention; Other: Questionnaire Administration; Other: Quality of Life Assessment
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Diagnosed with head and neck cancer including cancers of the sinuses, oral cavity, oropharynx, hypopharynx, or larynx (all stages); therapeutically eligible to receive at least three months of immunotherapy
- Medically cleared by oncologist to engage in aerobic and resistance exercise intervention
- 18 years of age or older
- Access to a smartphone and have an active wi-fi connection at home
- Able to read and/or to speak English
- Able to comprehend and sign a written informed consent (no cognitive decline)
- Women of reproductive potential must have a negative serum or urine pregnancy test within the week prior to starting therapy
- Severe or unstable cardiopulmonary, metabolic, or renal disease as determined by the referring oncologist
- Unable to walk safely without physical assistance of another person
- Any condition that may limit the ability to comply with behavioral recommendations of the program
- Pregnant or planning a pregnancy
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 22, 2025. Always confirm current availability with the study team.